The organization behind this landmark event, Shir for Life, was founded by Einat Dado-Baralia with a singular purpose: to rewrite the narrative around neuroblastoma
Children with relapsed or treatment-refractory neuroblastoma could soon be treated with third-generation of CAR T cells with a suicide safety switch, after a promising results from phase 1/2 trial.